Lusaka [Zambia], July 8 (ANI/Xinhua): Zambia will soon start administering Paxlovid, an oral antiviral pill, to people at risk of developing severe COVID-19 disease, its health ministry said on Friday.

Chennai (Tamil Nadu) [India], March 15 (ANI/NewsVoir): Kauvery Hospital Chennai, a unit of Kauvery Group of Hospitals, a leading multispecialty healthcare chain in Tamil Nadu, today announced the successful treatment of a doctor, with severe COVID-19 infection and 99 per cent lung involvement leading to respiratory failure.

Ottawa [Canada], January 24 (ANI): Remdesivir had saved many lives during the deadly second wave of COVID-19. Now, a new research has revealed that Remdesivir, when compared with the standard of care for COVID-19, reduced the need for mechanical ventilation in hospitalised patients.

New Delhi [India], December 30 (ANI): Out of 209 sample tests that have been conducted so far in Lok Nayak Jai Prakash Narayan Hospital (LNJP), 96 patients have been detected Omicron positive in the genome sequencing report, Dr Suresh Kumar, Medical Director LNJP Hospital said on Thursday.

New Delhi [India], December 26 (ANI): Patients who were suffering from Omicron variant of COVID-19 have recovered without the use of oxygen support, steroids, Remdesivir or ventilator, said Dr Suresh Kumar, MD, Lok Nayak Jai Prakash Narayan Hospital.

New Delhi Dec 24 PTI The Centre on Friday said Remdesivir drug should only be used in patients with moderate to severe COVID-19 and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom It also warned against use of the drug in patients who are not on oxygen support or in home settings According to the clinical guidance issued by the Union health ministry for management of the infection in adult patients Remdesivir has been asked to be used in patients with moderate to severe COVID-19 and those with no renal or hepatic dysfunction within 10 days of onset of any symptom The Tocilizumab drug may be considered for use in the presence of severe disease preferably within 24 to 48 hours of onset of severe diseaseICU admission according to the guidelines Tocilizumab can be used in case of significantly raised inflammatory markers CRP or IL-6 condition not improving despite use of steroids and no active bacterialfungaltubercular infection The ministry also said that those above 60 years of age with cardiovascular disease hypertension diabetes and other immunocompromised states are at high risk for severe disease and mortality According to the guidelines coronavirus patients have been classified into those affected by mild moderate and severe disease For mild disease home isolation and care is recommended while admission in a ward is recommended for those battling moderate disease and ICU has been recommended for patients with severe COVID-19 they added PTI UZM SRY

New Delhi [India], November 18 (ANI): The Delhi High Court has granted bail to four accused persons in connection with alleged illegal holding and selling of Remdesivir injections during the second wave of the COVID-19 pandemic.

New Delhi [India], November 8 (ANI/ATK): StayHappi Pharmacy has established itself as one of the most competitive and active pharmaceutical brands in the Indian market facilitating high-quality medicines at 'real and affordable' price.